SOAT1 and metabolic dysfunction-associated steatotic liver disease: Moreover, nootkatone supplementation reduced the expression of SOAT1, alleviated hepatic steatosis and pathological injuries damage, which suppressed tumorigenesis and development of NAFLD-HCC.